Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127333511 | 12733351 | 1 | I | 20110830 | 20160907 | 20160912 | 20160912 | EXP | US-009507513-1609USA003955 | MERCK | 74.00 | YR | F | Y | 69.00000 | KG | 20160912 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127333511 | 12733351 | 1 | PS | PRINIVIL | LISINOPRIL | 1 | Oral | 40 MG, QD | Y | 19558 | 40 | MG | TABLET | QD | |||||
| 127333511 | 12733351 | 2 | SS | ASPIRIN. | ASPIRIN | 1 | Oral | 325 MG, QD | 0 | 325 | MG | TABLET | QD | ||||||
| 127333511 | 12733351 | 3 | SS | IBUPROFEN. | IBUPROFEN | 1 | Oral | UNK, TID | 0 | TABLET | TID | ||||||||
| 127333511 | 12733351 | 4 | SS | IBUPROFEN. | IBUPROFEN | 1 | 0 | TABLET | |||||||||||
| 127333511 | 12733351 | 5 | C | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | UNK | 0 | |||||||||||
| 127333511 | 12733351 | 6 | C | AMLODIPINE BESYLATE. | AMLODIPINE BESYLATE | 1 | UNK | Y | 0 | ||||||||||
| 127333511 | 12733351 | 7 | C | AMLODIPINE BESYLATE. | AMLODIPINE BESYLATE | 1 | UNK | Y | 0 | ||||||||||
| 127333511 | 12733351 | 8 | C | HYDRALAZINE | HYDRALAZINE HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 127333511 | 12733351 | 9 | C | LASIX | FUROSEMIDE | 1 | UNK | 0 | |||||||||||
| 127333511 | 12733351 | 10 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 127333511 | 12733351 | 11 | C | VYTORIN | EZETIMIBESIMVASTATIN | 1 | UNK | 0 | TABLET | ||||||||||
| 127333511 | 12733351 | 12 | C | INSULIN | INSULIN NOS | 1 | UNK, BID | 0 | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127333511 | 12733351 | 1 | Hypertension |
| 127333511 | 12733351 | 2 | Thrombosis prophylaxis |
| 127333511 | 12733351 | 3 | Rheumatoid arthritis |
| 127333511 | 12733351 | 4 | Osteoarthritis |
| 127333511 | 12733351 | 5 | Prophylaxis |
| 127333511 | 12733351 | 6 | Hypertension |
| 127333511 | 12733351 | 8 | Hypertension |
| 127333511 | 12733351 | 9 | Hypertension |
| 127333511 | 12733351 | 10 | Diabetes mellitus |
| 127333511 | 12733351 | 11 | Dyslipidaemia |
| 127333511 | 12733351 | 12 | Diabetes mellitus |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127333511 | 12733351 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127333511 | 12733351 | Angioedema |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127333511 | 12733351 | 1 | 200711 | 20110830 | 0 | |
| 127333511 | 12733351 | 2 | 2004 | 0 | ||
| 127333511 | 12733351 | 3 | 20080225 | 20110818 | 0 | |
| 127333511 | 12733351 | 5 | 20080225 | 20110818 | 0 | |
| 127333511 | 12733351 | 6 | 20060628 | 20110830 | 0 | |
| 127333511 | 12733351 | 7 | 201111 | 0 | ||
| 127333511 | 12733351 | 8 | 2000 | 0 | ||
| 127333511 | 12733351 | 9 | 200005 | 0 | ||
| 127333511 | 12733351 | 10 | 1990 | 0 | ||
| 127333511 | 12733351 | 11 | 20091229 | 0 | ||
| 127333511 | 12733351 | 12 | 1990 | 0 |